Clinical Research Directory
Browse clinical research sites, groups, and studies.
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension
Sponsor: University of Florida
Summary
The goal of this clinical trial is to learn about the mechanisms by which minocycline effect blood pressure in individuals with treatment-resistant hypertension. The main questions it aims to answer are: * To what extent does minocycline lower blood pressure? * Are such blood pressure effects mediated through changes in gut microbiota, gut leakiness, systemic inflammation, neuroinflammation, or some combination of these? Participants will be randomly assigned to treatment with minocycline or placebo, treated daily for 3 months, to evaluate these questions.
Official title: Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the Gut Microbiota-brain-immune Axis
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-01-08
Completion Date
2028-07
Last Updated
2026-03-06
Healthy Volunteers
No
Interventions
Minocycline Hydrochloride
Minocycline Hydrochloride 100 mg twice daily
Placebo
Placebo
Locations (1)
UF Clinical Research Center (UF CRC) - CTSI
Gainesville, Florida, United States